Early extubation is not associated with severe intraventricular hemorrhage in preterm infants born before 29 weeks of gestation. Results of an EPIPAGE-2 cohort study.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2019
Historique:
received: 05 10 2018
accepted: 09 03 2019
entrez: 5 4 2019
pubmed: 5 4 2019
medline: 19 12 2019
Statut: epublish

Résumé

To determine whether there is an association between severe intraventricular hemorrhage and early extubation in preterm infants born before 29 weeks of gestational age and intubated at birth. This study included 1587 preterm infants from a nationwide French population cohort (EPIPAGE-2). Secondary data on intubated preterm infants were analyzed. After gestational age and propensity score matching (1:1) we built two comparable groups: an early extubation group and a delayed extubation group. Each neonate in one group was paired with a neonate in the other group having the same propensity score and gestational age. Early extubation was defined as extubation within 48 hours of life. Severe intraventricular hemorrhages were defined as grade III or IV hemorrhages according to the Papile classification. After matching, there were 398 neonates in each group. Using a generalized estimating equation model, we found that intraventricular hemorrhage was not associated with early extubation (adjusted OR 0.9, 95%CI 0.6-1.4). This result was supported by sensitivity analyses. The practice of early extubation was not associated with an increased proportion of intraventricular hemorrhages. To complete these results, the long-term neurologic outcomes of these infants need to be assessed.

Identifiants

pubmed: 30946750
doi: 10.1371/journal.pone.0214232
pii: PONE-D-18-29012
pmc: PMC6448867
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0214232

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Semin Perinatol. 2006 Aug;30(4):192-9
pubmed: 16860159
Semin Fetal Neonatal Med. 2015 Aug;20(4):232-7
pubmed: 25818879
Am J Perinatol. 2014 Dec;31(12):1063-72
pubmed: 24683068
J Pediatr. 2016 Oct;177:144-152.e6
pubmed: 27233521
Health Serv Res. 2014 Oct;49(5):1701-20
pubmed: 24779867
J Matern Fetal Neonatal Med. 2015;28(17):2115-20
pubmed: 25354288
N Engl J Med. 2010 May 27;362(21):1970-9
pubmed: 20472939
Eur J Paediatr Neurol. 2001;5(4):139-49
pubmed: 11587377
JAMA Pediatr. 2015 Nov;169(11):1011-7
pubmed: 26414549
J Perinatol. 2014 May;34(5):399-404
pubmed: 24556980
Pediatr Neurol. 2006 Aug;35(2):85-92
pubmed: 16876002
Front Med (Lausanne). 2015 Dec 21;2:90
pubmed: 26734611
J Pediatr. 2017 Oct;189:113-119.e2
pubmed: 28600154
Ann Saudi Med. 2011 Nov-Dec;31(6):577-80
pubmed: 22048501
N Engl J Med. 2008 Feb 14;358(7):700-8
pubmed: 18272893
J Pediatr. 1978 Apr;92(4):529-34
pubmed: 305471
Semin Fetal Neonatal Med. 2009 Feb;14(1):21-7
pubmed: 18974027
BMC Pediatr. 2014 Apr 09;14:97
pubmed: 24716860
Stroke. 2010 Dec;41(12):2901-7
pubmed: 20966409
Clin Perinatol. 2009 Dec;36(4):723-36, v
pubmed: 19944832
J Pediatr. 2016 Jun;173:45-9
pubmed: 26960919
Arch Dis Child Fetal Neonatal Ed. 2010 Jan;95(1):F53-8
pubmed: 19679893
Am J Respir Crit Care Med. 2011 Jun 15;183(12):1715-22
pubmed: 21471086
N Engl J Med. 1994 Oct 20;331(16):1051-5
pubmed: 8090164
Front Pediatr. 2017 Apr 03;5:64
pubmed: 28421173
Arch Dis Child Fetal Neonatal Ed. 2015 Sep;100(5):F428-31
pubmed: 26063193
Lancet. 1992 Feb 1;339(8788):283-7
pubmed: 1346292
J Pediatr. 2013 Apr;162(4):698-704.e2
pubmed: 23140883
Acta Paediatr. 2010 Jul;99(7):978-92
pubmed: 20456261
Arch Dis Child Fetal Neonatal Ed. 2008 Sep;93(5):F368-71
pubmed: 18089627
Pediatrics. 2014 Jan;133(1):55-62
pubmed: 24379238
Neonatology. 2010 Jun;97(4):402-17
pubmed: 20551710
Pediatrics. 2004 Nov;114(5):1341-7
pubmed: 15520119
Arch Dis Child Fetal Neonatal Ed. 2017 Nov;102(6):490-496
pubmed: 28302697
Arch Dis Child. 1981 Dec;56(12):900-4
pubmed: 7332336

Auteurs

Marie Chevallier (M)

UMR 5525 ThEMAS, CNRS, TIMC-IMAG, Grenoble Alpes University, Grenoble, France.
Neonatal Intensive Care Unit, Grenoble Alpes University Hospital, Grenoble, France.

Pierre-Yves Ancel (PY)

Obstetrical, Perinatal, and Pediatric Epidemiology ResearchTeam (Epopé), INSERM UMR 1153, Center for Epidemiology and Biostatistics Sorbonne Paris Cité; Paris Descartes University, Paris, France.
Risk in Pregnancy DHU, Cochin Hotel-Dieu Hospital, APHP, Paris, France.

Héloïse Torchin (H)

Obstetrical, Perinatal, and Pediatric Epidemiology ResearchTeam (Epopé), INSERM UMR 1153, Center for Epidemiology and Biostatistics Sorbonne Paris Cité; Paris Descartes University, Paris, France.

Laetitia Marchand-Martin (L)

Obstetrical, Perinatal, and Pediatric Epidemiology ResearchTeam (Epopé), INSERM UMR 1153, Center for Epidemiology and Biostatistics Sorbonne Paris Cité; Paris Descartes University, Paris, France.

Elsa Lorthe (E)

Obstetrical, Perinatal, and Pediatric Epidemiology ResearchTeam (Epopé), INSERM UMR 1153, Center for Epidemiology and Biostatistics Sorbonne Paris Cité; Paris Descartes University, Paris, France.
EPIUnit-Institute of Public Health, University of Porto, Porto, Portugal.

Patrick Truffert (P)

Neonatal Intensive Care Unit, Jeanne de Flandre Hospital, CHRU Lille, Lille, France.

Pierre Henri Jarreau (PH)

Risk in Pregnancy DHU, Cochin Hotel-Dieu Hospital, APHP, Paris, France.
Neonatal Intensive Care Unit Port-Royal, Hôpital Cochin, APHP Paris, France.

Jean Christophe Roze (JC)

Department of Neonatal Medicine, CHU Nantes, Nantes, France.

Véronique Pierrat (V)

Obstetrical, Perinatal, and Pediatric Epidemiology ResearchTeam (Epopé), INSERM UMR 1153, Center for Epidemiology and Biostatistics Sorbonne Paris Cité; Paris Descartes University, Paris, France.
Neonatal Intensive Care Unit, Jeanne de Flandre Hospital, CHRU Lille, Lille, France.

Stéphane Marret (S)

Department of Neonatal Medicine and Intensive care, CHU Rouen, Rouen, France.

Olivier Baud (O)

Division of Neonatology and Pediatric Intensive Care, CHU Geneva, Geneva, Switzerland.

Valérie Benhammou (V)

Obstetrical, Perinatal, and Pediatric Epidemiology ResearchTeam (Epopé), INSERM UMR 1153, Center for Epidemiology and Biostatistics Sorbonne Paris Cité; Paris Descartes University, Paris, France.

Anne Ego (A)

UMR 5525 ThEMAS, CNRS, TIMC-IMAG, Grenoble Alpes University, Grenoble, France.

Thierry Debillon (T)

UMR 5525 ThEMAS, CNRS, TIMC-IMAG, Grenoble Alpes University, Grenoble, France.
Neonatal Intensive Care Unit, Grenoble Alpes University Hospital, Grenoble, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH